Tapan, Umit <br/><br/>
Epstein-Barr virus-associated diffuse large B-cell lymphoma arising in atrial myxoma: a proposal for a modified therapeutic approach.  [electronic resource] 

 -  Leukemia & lymphoma  Feb 2015 
 - 505-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2014.919632  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD20--metabolism<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cyclophosphamide--administration & dosage<br/>Epstein-Barr Virus Infections--etiology<br/>Epstein-Barr Virus Nuclear Antigens--metabolism<br/>Etoposide--administration & dosage<br/>Fatal Outcome<br/>Heart Atria--pathology<br/>Heart Neoplasms--complications<br/>Herpesvirus 4, Human--isolation & purification<br/>Host-Pathogen Interactions<br/>Humans<br/>Immunohistochemistry<br/>Interferon Regulatory Factors--metabolism<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Myxoma--complications<br/>Prednisone--administration & dosage<br/>Rituximab--administration & dosage<br/>Vincristine--administration & dosage<br/>Viral Proteins--metabolism